Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116907) titled 'Efficacy of Kutajastak avaleha drug in heavy menstrual bleeding' on Sept. 2.

Study Type: Interventional

Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Case Record Numbers Blinding and masking:Participant Blinded

Primary Sponsor: PMT Ayurved College and Shri eknath rugnalaya

Condition: Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Recruitment Status: Not Recruiting

Phase: Phase 2/ Phase 3

Date of First Enrollment: 14-09-2026

Target Sample Size: 64

Co...